Creotech Quantum, a Polish company listed on the Warsaw Stock Exchange that develops and commercialises quantum technologies, has launched a process to raise approximately PLN 75 million through the issue of up to 350,000 series D ordinary bearer shares.
The offering will be conducted as a private subscription addressed to selected investors, with the pre-emptive rights of existing shareholders fully excluded. The funds raised will be used to implement the company’s growth strategy and support its transition into a phase of dynamic expansion.
In particular, the proceeds are expected to allow Creotech Quantum to pursue a broader range of strategic initiatives, including potential development and investment projects that may arise in the course of its future operations. The company is supported in the process by cc group as investor relations and financial adviser, while Dom Maklerski Banku Ochrony Środowiska S.A. is acting as coordinator of the offering.
“The launch of the financing process is an important step in implementing our long-term growth strategy and building Creotech Quantum’s strong position on the European quantum technology market. We decided to increase the target value of financing from the previously planned PLN 60 million to PLN 75 million. The additional capital will allow us to accelerate key R&D work and the implementation of new products, as well as to make better use of emerging market opportunities. We are focusing on areas with the greatest market potential, such as quantum communication, data security, critical infrastructure, and solutions for the telecommunications and space sectors. At the same time, we plan to strengthen production, integration and sales capabilities, expand our presence in foreign markets, and invest in infrastructure and engineering facilities. Our goal is to build a company capable of delivering advanced quantum technologies internationally and actively participating in the development of European technological sovereignty in this area,” said Dr Anna Kamińska, President of the Management Board of Creotech Quantum S.A.
Funds to support R&D and commercialisation
In line with earlier announcements, the company plans to allocate approximately 50–65% of the proceeds from the issue to the further development of research and development activities and the expansion of the organisation. At the same time, Creotech Quantum intends to continue co-financing R&D projects from external sources, including national and international programmes carried out, among others, for the European Commission and the European Space Agency.
In this area, the company will focus primarily on the development of a new generation of quantum key distribution systems, single-photon detectors, receivers for optical ground stations, as well as solutions in the field of space security and electronics for quantum processors. In parallel, Creotech Quantum plans to invest in strengthening security infrastructure, expanding its engineering base, and increasing its integration and testing capabilities.
The remaining part of the proceeds will be used to develop commercial activities and to implement and sell products, in particular the company’s first QKD system and further solutions in this area. Creotech Quantum also plans to develop and build demonstration devices used in pilot projects, increase the production scale of its own technologies, and strengthen its sales and marketing capabilities.
A further important element of the company’s plans will be continued expansion into foreign markets and active participation in key industry events.
Possible acquisitions remain on the table
As part of the implementation of its strategy and the use of funds raised from the issue, the company does not rule out acquisitions or partial acquisitions of entities that are complementary in technological or business terms. Such transactions could help accelerate business development, broaden competencies and strengthen Creotech Quantum’s market position.
Increasing the target value of the issue is intended to improve the company’s ability to act in this area and enable participation in larger tenders that require sufficient financial liquidity.
Details of the series D share issue
The series D share issue is being carried out with the full exclusion of pre-emptive rights of existing shareholders. The offer will be addressed only to selected investors: no more than 149 natural or legal persons other than qualified investors, as well as investors who acquire shares with a total value of at least EUR 100,000 per investor.
At the same time, shareholders meeting the criteria set out in the issue resolution will have priority rights to subscribe for the new shares. This mechanism is intended to protect against voting dilution those shareholders who have made significant investments in the company’s shares.
The priority right will apply to shareholders who, as at the end of 11 May, held at least 14,272 shares in the company, representing approximately 0.5% of the share capital and total voting rights. When calculating the 0.5% threshold, the company’s treasury shares in the share capital are not taken into account, namely 1,500,000 series A ordinary registered shares.
The funds raised through the series D share issue are intended to enable Creotech Quantum to consistently implement its development strategy and build solid organisational foundations for a company capable of delivering advanced quantum technologies on an international scale.
